Andreas Luxenburger

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 10

Top Topics

Breast Cancer Cells

Capillary Electrophoresis

Top Venues

Journal of medicinal chemistry

Archiv der Pharmazie

Organic & biomolecular chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Luxenburger, Hannah Clemmens, Christopher Hastings, Lawrence D Harris, Elizabeth M Ure, Scott A Cameron, Jan Aasly, Oliver Bandmann, Alex Weymouth-Wilson, Richard H Furneaux, Heather Mortiboys
3α,7-Dihydroxy-14(13→12) abeo -5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's Disease. Biomolecules 13 (1) (2022)
Farah Lamiable-Oulaidi, Rajesh K Harijan, Karl J Shaffer, Douglas R Crump, Yan Sun, Quan Du, Shivali A Gulab, Ashna A Khan, Andreas Luxenburger, Anthony D Woolhouse, Simone Sidoli, Peter C Tyler, Vern L Schramm
Synthesis and Characterization of Transition-State Analogue Inhibitors against Human DNA Methyltransferase 1. Journal of medicinal chemistry 65 (7) (2022)
Roselis A Landaeta Aponte, Andreas Luxenburger, Scott A Cameron, Alex Weymouth-Wilson, Richard H Furneaux, Lawrence D Harris, Benjamin J Compton
Synthesis of Novel C/D Ring Modified Bile Acids. Molecules (Basel, Switzerland) 27 (7) (2022)
Andreas Luxenburger, Hannah Clemmens, Christopher Hastings, Lawrence D Harris, Elizabeth M Ure, Scott A Cameron, Jan Aasly, Oliver Bandmann, Alex Weymouth-Wilson, Richard H Furneaux, Heather Mortiboys
3α,7-Dihydroxy-14(13→12) abeo -5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's Disease. Biomolecules 13 (1) (2022)
Elizabeth M Ure, Lawrence D Harris, Scott A Cameron, Alex Weymouth-Wilson, Richard H Furneaux, Janet L Pitman, Simon F R Hinkley, Andreas Luxenburger
Synthesis of 12β-methyl-18- nor -avicholic acid analogues as potential TGR5 agonists. Organic & biomolecular chemistry 20 (17) (2022)
Andreas Luxenburger, Hannah Clemmens, Christopher Hastings, Lawrence D Harris, Elizabeth M Ure, Scott A Cameron, Jan Aasly, Oliver Bandmann, Alex Weymouth-Wilson, Richard H Furneaux, Heather Mortiboys
3α,7-Dihydroxy-14(13→12) abeo -5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's Disease. Biomolecules 13 (1) (2022)
Andreas Luxenburger, Hannah Clemmens, Christopher Hastings, Lawrence D Harris, Elizabeth M Ure, Scott A Cameron, Jan Aasly, Oliver Bandmann, Alex Weymouth-Wilson, Richard H Furneaux, Heather Mortiboys
3α,7-Dihydroxy-14(13→12) abeo -5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's Disease. Biomolecules 13 (1) (2022)
Thorsten von Drathen, Elizabeth M Ure, Stefan Kirschner, Aileen Roth, Laura Meier, Anthony D Woolhouse, Scott A Cameron, Uwe Knippschild, Christian Peifer, Andreas Luxenburger
C5-Iminosugar modification of casein kinase 1δ lead 3-(4-fluorophenyl)-5-isopropyl-4-(pyridin-4-yl)isoxazole promotes enhanced inhibitor affinity and selectivity. Archiv der Pharmazie 355 (5) (2022)
Andreas Luxenburger, Nicola Bougen-Zhukov, Michael G Fraser, Henry Beetham, Lawrence D Harris, Dorian Schmidt, Scott A Cameron, Parry J Guilford, Gary B Evans
Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer. Journal of medicinal chemistry (2021)
Andreas Luxenburger, Lawrence D Harris, Elizabeth M Ure, Roselis A Landaeta Aponte, Anthony D Woolhouse, Scott A Cameron, Chris D Ling, Ross O Piltz, Andrew R Lewis, Graeme J Gainsford, Alex Weymouth-Wilson, Richard H Furneaux
Synthesis of 12β-Methyl-18-nor-bile Acids. ACS omega 6 (38) (2021)